New Enterprise Associates 17, L.P.

New Enterprise Associates 17, L.P. is a declared insider at 5 companies; the most frequent names are Korro Bio, Inc., MBX Biosciences, Inc. and Monte Rosa Therapeutics, Inc. In total, 6 filings cover trades dated from 28 June 2021 to 10 March 2026.

No open-market sale appears; the market trades are 2 purchases worth €2.9M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 1 share grant. In 2026 alone, the filings show 1 purchase and no sales.

The latest filing, published on 12 March 2026, reports an open-market purchase of €2.0M in Korro Bio, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.